# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001437749-26-022206
Filing Date
2026-07-01
Accepted
2026-07-01 06:01:30
Documents
10
Period of Report
2026-07-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | athe20260701_6k.htm | 6-K | 10825
2 | EXHIBIT 99.1 | ex_983540.htm | EX-99.1 | 4362
3 |  | a01.jpg | GRAPHIC | 80715
4 |  | a02.jpg | GRAPHIC | 63710
5 |  | a03.jpg | GRAPHIC | 54003
6 |  | a04.jpg | GRAPHIC | 147833
7 |  | a05.jpg | GRAPHIC | 61182
8 |  | a06.jpg | GRAPHIC | 30470
9 |  | a07.jpg | GRAPHIC | 166706
10 |  | a08.jpg | GRAPHIC | 46071
| Complete submission text file | 0001437749-26-022206.txt |  | 911933

Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 261142438
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)